Skip to content
Vulnerability Intelligence

CVE-2022-2143

CriticalPublic exploit

The affected product is vulnerable to two instances of command injection, which may allow an attacker to remotely execute arbitrary code.

Published Jun 29, 2022 · Updated Apr 16, 2025

Key Facts

Patch immediately
  • CVE-2022-2143 is a critical-severity vulnerability (CVSS 9.8 v3.1) affecting iView (Advantech).
  • It is not listed in any known-exploited vulnerabilities catalog. Public exploit code is available.
  • EPSS estimates a 60% probability of exploitation in the next 30 days.
  • Fixed versions are available, including iView 5.7.04.6469, iView 5_7_04_6469.
  • Brandefense priority: patch immediately, because it is very likely to be exploited soon.

CVSS v3.1

9.8

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

EPSS (30-day exploit likelihood)

60%

Higher than 99.1% of all scored CVEs

Exploited in the wild

No known

Not in a known-exploited catalog

Public exploit code

Available

Proof-of-concept or weaponized module

Get the full CVE-2022-2143 brief as a PDF

Every affected product and fixed release, exploitation status and a first 24 hours response checklist, emailed within minutes.

Description

The affected product is vulnerable to two instances of command injection, which may allow an attacker to remotely execute arbitrary code.

Affected Products

2 affected entries in total
ProductAffected versionsFixed in
iViewAdvantech>= All5.7.04.6469

Patched Releases

iView

5.7.04.6469, 5_7_04_6469

Timeline

  1. Publicly disclosed

    Jun 29, 2022

  2. Last updated

    Apr 16, 2025

Weakness Type

  • CWE-77 Improper Neutralization of Special Elements used in a Command ('Command Injection')

References

FAQ

Common Questions.

Is CVE-2022-2143 Running On Your Attack Surface?

Brandefense maps vulnerabilities like this one to your internet-facing assets and tells you exactly where to patch.

Request A Demo